EPAS1 and glioblastoma: Interestingly, in vitro treatment of the PDX cell lines with PT2385 did not impact cell proliferation or viability, suggesting that the drug affected other cells of the TME; however, whether HIF-2α inhibition impacts the immune cells of the GBM tumor microenvironment has not been assessed.